Kelly Grez

Merck & Co., Inc.

Assets Managed

$349.438M

Holdings

Last Quarter

2026 - Q1

Filed Date

19d ago

Growth Rate

26.49%(2Q avg: 23.82%)

Sustained Growth

4 quarters

Portfolio positions

This chart displays the top 10 holdings in Merck & Co., Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 14 positions.

Assets under management

The assets under management (AUM) of Merck & Co., Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 349.438M in assets, with a quarterly growth rate of 26.49% and a 2-quarter average growth rate of 23.82%. The portfolio is managed by Kelly Grez, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
MRNA Moderna Inc Recent Activity	33.56%	$117.256M 2.308M shares@ $50.8 avg price
PSNL Personalis Inc Recent Activity	25.61%	$89.466M 14.045M shares@ $6.38 avg price
KYMR Kymera Therapeutics Inc Recent Activity	18.41%	$64.314M 772,165 shares@ $83.3 avg price
ur-7⤦ Entrada Therapeutics Inc Recent Activity	6.29%	$21.956M 1.74M shares@ $12.62 avg price
EIKN Eikon Therapeutics Inc Recent Activity New Position	5.05%	$17.633M 1.667M shares@ $10.58 avg price	New Position
AKTS Aktis Oncology Inc Recent Activity New Position	4.88%	$17.046M 952,844 shares@ $17.89 avg price	New Position
ALEC Alector Inc Recent Activity	2.19%	$7.623M 3.546M shares@ $2.16 avg price
STRO Sutro Biopharma Inc Recent Activity	1.95%	$6.784M 272,351 shares@ $24.91 avg price
EVAX Evaxion Biotech A S Recent Activity	1.3%	$4.517M 1.214M shares@ $3.73 avg price
VRDN Viridian Therapeutics Inc Recent Activity	0.53%	$1.827M 93,414 shares@ $19.57 avg price

1-10 of 14